Nuklearmedizin 1990; 29(01): 35-39
DOI: 10.1055/s-0038-1629510
Originaler Artikel
Schattauer GmbH

Internal Mammarial Lymphoscintigraphy with SPECT after Ultrasound-Guided Injection of 99mTc-Dextran[*]

Interne Mammial Lymphoszintigraphie mit SPECT nach Ultraschall-Guided Injektion von 99mTc-Dextran
M. Ünlü
1   From the Departments of Nuclear Medicine, Ankara, Turkey
,
T.M. Ercan
1   From the Departments of Nuclear Medicine, Ankara, Turkey
,
H. Alanyali
2   From the Departments of Radiotherapy, Ankara, Turkey
,
O. Akhan
3   From the Departments of Radiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
F.C. Bekdik
1   From the Departments of Nuclear Medicine, Ankara, Turkey
› Author Affiliations
Further Information

Publication History

Received: 09 October 1989

in revised form: 24 November 1989

Publication Date:
04 February 2018 (online)

Twenty-two women with stage II or III breast cancer were evaluated by SPECT to determine the number, size, three-dimensional localization and depth from skin surface of the internal mammary lymph nodes for accurate radiotherapy portal planning. The results were also compared with those of planar imaging (PI). Two-step injections of 99mTc-dextran were made under ultrasound guidance into the anterior sheath of the M. rectus abdominis first at the ablation side. 1.5 h thereafter an anterior planar view was obtained to evaluate cross drainage (13.6% was observed). Then, the second injection was done at the opposite side in the same manner. Planar and tomographic images were obtained 1.5 h after the second injection. Similar values were obtained for the depth from skin surface, distance from the midline and diameter of the lymph nodes with both PI and SPECT. The total number of nodes in 22 patients detected by SPECT was higher (138) than that from PI (129), the difference being statistically significant (0.005 > p >0.0005).

Zusammenfassung

Um die Anzahl, Größe, dreidimensionale Lokalisation und Tiefe unter der Hautoberfläche parasternaler Lymphknoten zwecks exakter Planung der Radiotherapie eines Mamma-Karzinoms zu bestimmen, wurden 22 Frauen mit Mamma-Karzinom der Stadien II oder III mittels SPECT untersucht. Die Ergebnisse wurden mit jenen einer planaren Szintigraphie (PS) verglichen. 99mTc-Dextran wurde in zwei Stufen unter Ultraschall-Kontrolle in die vordere Scheide des M. rectus abdominis injiziert. Die erste erfolgte auf der Seite der Ablation; 1.5h später zeigte ein planares Bild die eventuelle Drainage zur anderen Seite (beobachtet bei 13,6% der Fälle). Die zweite Injektion erfolgte auf der anderen Seite; jetzt wurde nach 1.5h sowohl eine PS als auch eine SPECT durchgeführt. Beide Methoden ergaben ähnliche Werte für die Tiefe unter der Haut und die Größe der Lymphknoten sowie für ihren Abstand von der Mittellinie. Die Anzahl der diagnostizierten Knoten war jedoch bei der SPECT mit 138 höher als jene bei der PS (129), wobei diese Differenz signifikant war (0,005 >p >0,0005).

* This work was presented in part as a poster at the European Association of Nuclear Medicine Congress, Aug. 28-Sept. 1, 1989, Strasbourg, France.


 
  • REFERENCES

  • 1 Bernardino M E, Sponos Jr W. A simple technique for determining internal mammary chain depth by sonography. Int J Radiat Oncol Biol Phys 1981; 07: 671-3.
  • 2 Bronskill M J, Harauz G, Ege G N. Computerized internal mammary lymphoscintigraphy in radiation treatment planning of patients with breast carcinoma. Int J Radiat Oncol Biol Phys 1979; 05: 573-9.
  • 3 Collier B D, Palmer D W, Wilson F J. et al. Internal mammary lymphoscintigraphy in patients with breast cancer. Correlation withcomputed tomography and impact on radiation therapy planning. Radiology 1983; 147: 845-8.
  • 4 Ege G N. Internal mammarial lymphoscintigraphy: a rational adjunct to the staging and management of breast carcinoma. Clin Radiol 1978; 29: 453-6.
  • 5 Ercan M T, Schncidereit M, Senekowitsch R, Kriegei H. Evaluation of 99mTc-dextran as a lymphoscintigraphic agent in rabbits. Eur J Nucl Med 1985; 11: 80-4.
  • 6 Henze E, Schelbert H R, Collins J D. et al. Lymphoscintigraphy with 99mTc labelled dextran. J Nucl Med 1982; 23: 923-9.
  • 7 Jones D, Hanelin L, Cristopherson D. et al. Radiotherapy treatment planning using lymphoscintigraphy. Int J Radiat Oncol Biol Phys 1986; 12: 1707-10.
  • 8 Karayalcin B, Aras G, Erbay G, Ercan M T. Parasternal lymphoscintigraphy using 99mTc- dextran. Nucl Med Commun 1988; 09: 657-62.
  • 9 Kaplan W D, Anderson J W, Siddon R L. et al. The three-dimensional localization of internal mammary lymph nodes by radionuclide lymphoscintigraphy. J Nucl Med 1988; 29: 473-8.
  • 10 Neils E W. Ultrasonic guidance for internal mammary lymphoscintigraphy. J Nucl Med 1988; 29: 1744-5.
  • 11 Sorensen B. Recherches sur la localisation des ganglions lymphatiques parasternaux par rapport aux espaces intercostaux. J Int Chir 1951; 11: 501-9.
  • 12 Terui S, Yamamato H. New simplified lymphoscintigraphic technique in patients with breast cancer. J Nucl Med 1989; 30: 1198-204.
  • 13 Recht A, Siddon R L, Kaplan W D, Andersen J W, Harris J R. Three-dimensional internal mammary lymphoscintigraphy: implications for radiation treatment planning for breast carcinoma. Int J Radiot Oncol Biol Phys 1988; 14: 477-81.
  • 14 Weichselbaum R R, March A, Heilman S. The role of postoperative irradiation in carcinoma of the breast. Cancer 1976; 37: 2682-90.
  • 15 Wingärdh K, Strend S E. Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy. Eur J Nucl Med 1989; 15: 146-51.
  • 16 Yip T CK, Ege G N. Determination of depth distribution of internal mammary lymph nodes on lateral lymphoscintigraphy. Clin Radiol 1985; 36: 149-52.